Considering the importance of HER2-low as a predictive biomarker and its substantial temporal and spatial heterogeneity every effort should be made in routine practice to obtain tumour tissue at multiple timepoints, a lesson previously learned from the similar example of ER expression [32, 33]. The gene discussed is ERBB2; the disease is neoplasm.